Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Neonatal Surg ; 6(3): 65, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28920025

RESUMEN

A term male baby, after delivery, was found to have a 3-centimeter beefy-red mass protruding from the left chest wall, adjacent to the left nipple. Radiological imaging suggested it's origin from the left lateral liver segment. A diagnostic laparoscopy confirmed the isolated connection to the liver, elevated left hemidiaphragm, and protrusion between the ribs. The mass was excised using electrocautery, and pathologic examination showed normal liver tissue.

2.
Am J Respir Cell Mol Biol ; 57(3): 307-314, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28421813

RESUMEN

Hemin, the oxidized prosthetic moiety of hemoglobin, has been implicated in the pathogenesis of acute chest syndrome in patients with sickle cell disease by virtue of its endothelial-activating properties. In this study, we examined whether hemin can cause lung microvascular endothelial barrier dysfunction. By assessing transendothelial resistance using electrical cell impedance sensing, and by directly measuring trans-monolayer fluorescein isothiocyanate-dextran flux, we found that hemin does cause endothelial barrier dysfunction in a concentration-dependent manner. Pretreatment with either a Toll-like receptor 4 inhibitor, TAK-242, or an antioxidant, N-acetylcysteine, abrogated this effect. Increased monolayer permeability was found to be associated with programmed cell death by necroptosis, as evidenced by Trypan blue staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling assay, Western blotting for activated forms of key effectors of cell death pathways, and studies utilizing specific inhibitors of necroptosis and apoptosis. Further studies examining the role of endothelial cell necroptosis in promoting noncardiogenic pulmonary edema during acute chest syndrome are warranted and may open a new avenue of potential treatments for this devastating disease.


Asunto(s)
Apoptosis/efectos de los fármacos , Células Endoteliales/citología , Hemina/farmacología , Pulmón/irrigación sanguínea , Pulmón/fisiopatología , Microvasos/patología , Clorometilcetonas de Aminoácidos/farmacología , Caspasa 3/metabolismo , Deferoxamina/farmacología , Dextranos/metabolismo , Impedancia Eléctrica , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/metabolismo , Humanos , Imidazoles/farmacología , Etiquetado Corte-Fin in Situ , Indoles/farmacología , Hierro/metabolismo , Quelantes del Hierro/farmacología , Pulmón/efectos de los fármacos , Pulmón/patología , Modelos Biológicos , Necrosis , Estrés Oxidativo/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Coloración y Etiquetado , Receptor Toll-Like 4/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA